Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ESP Block for Post Cesarean Analgesia: Complete Statistical AnalysisIndependent statistical analysis of ESP Block for Post Cesarean Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05664958).
- ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery: Complete Statistical AnalysisIndependent statistical analysis of ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257941).
- ESPARTIndependent statistical analysis of Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ESPRITComplete statistical analysis of ESPRIT, the randomized phase 3 trial of recombinant interleukin-2 in HIV-positive patients receiving antiretroviral therapy, including time-to-event, longitudinal CD4, categorical, safety, and statistical interpretation.
- ESPRITIndependent statistical analysis of An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ESS-NSPASIndependent statistical analysis of A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test: primary endpoint results, effect estimate with confidence interval, sample-size…
- ESSAYIndependent statistical analysis of Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ESSBRIndependent statistical analysis of Efficacy Study of Single Stage Breast Reconstruction in Female Participants With Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ESSENCEIndependent statistical analysis of A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa: Complete Statistical AnalysisIndependent statistical analysis of ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ESSENTIALIndependent statistical analysis of Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243798).
- Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: Complete Statistical AnalysisIndependent statistical analysis of Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687892).
- ESTEEMIndependent statistical analysis of Combined Treatment for Mixed Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959347).
- ESTEEM 1Independent statistical analysis of Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab: Complete Statistical AnalysisIndependent statistical analysis of Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab: primary endpoint results, effect estimate with confidence interval,…
- Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01389102).
- ESTRELLAIndependent statistical analysis of A Study of Belcesiran in Patients With AATLD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764448).
- Estrogen and Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Estrogen and Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03436992).
- Estrogen and Fear in PTSD: Complete Statistical AnalysisIndependent statistical analysis of Estrogen and Fear in PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04192266).
- Estrogen and Serotonin on Changing Brain Chemistry: Complete Statistical AnalysisIndependent statistical analysis of Estrogen and Serotonin on Changing Brain Chemistry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01208324).
- Estrogen for Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Estrogen for Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01083641).
- Estrogen Variability and Irritability During the Menopause Transition: Complete Statistical AnalysisIndependent statistical analysis of Estrogen Variability and Irritability During the Menopause Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05388656).
- ET-01 in Subjects With Lateral Canthal Lines: Complete Statistical AnalysisIndependent statistical analysis of ET-01 in Subjects With Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03326856).
- ETA-TVIndependent statistical analysis of EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02877732).
- Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01230177).
- Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ETDAIndependent statistical analysis of Eustachian Tube Dysfunction Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667301).
- Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection: Complete Statistical AnalysisIndependent statistical analysis of Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ETIC-HHTIndependent statistical analysis of Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04139018).
- Etirinotecan Pegol (NKTR-102) in NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Etirinotecan Pegol (NKTR-102) in NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01773109).
- Etoposide in Patients With COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Etoposide in Patients With COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04356690).
- Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: Complete Statistical AnalysisIndependent statistical analysis of Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma: Complete Statistical AnalysisIndependent statistical analysis of Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EU RCTIndependent statistical analysis of ILLUMENATE EU Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858363).
- EUCLIDIndependent statistical analysis of A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EURAMOS-1Complete statistical analysis of EURAMOS-1, a randomized phase 3 trial of combination chemotherapy, peginterferon alfa-2b, and surgery in patients with localized or metastatic osteosarcoma.
- EURAMOS-1Independent statistical analysis of Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EUROMAXComplete statistical analysis of the EUROMAX phase 3 trial of bivalirudin versus standard-of-care heparins with optional GPI in acute coronary syndrome, including trial design, the primary binary endpoint, risk ratio, confidence interval,…
- European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT): Complete Statistical AnalysisIndependent statistical analysis of European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EURORELAXIndependent statistical analysis of Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04124757).
- EURTACIndependent statistical analysis of EURTAC, a randomized phase 3 trial comparing erlotinib with standard chemotherapy in advanced non-small cell lung cancer with EGFR TK-domain mutations, including progression-free survival, overall survival, trial design,…
- EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: Complete Statistical AnalysisIndependent statistical analysis of EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EUSpAIndependent statistical analysis of Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…